Navigation Links
InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
Date:2/17/2010

ll year 2009 was $48.7 million, compared with $48.2 million in 2008.  Total revenue for 2009 reflects higher revenue from the collaboration with Roche for the development of protease inhibitors.  Collaboration revenue in 2009 included a $20.0 million milestone in connection with the initiation of the Phase 2b study of RG7227.  Collaboration revenue in 2008 included a $15.0 million development milestone payment from Roche.

Research and development (R&D) expenses in the fourth quarter of 2009 were $21.2 million compared with $26.2 million in the fourth quarter of 2008.  R&D expenses were $89.1 million for the 12 months ended December 31, 2009, compared with $104.2 million in 2008.  Lower R&D expenses in both periods reflect completion of the CAPACITY clinical trials in early 2009, partially offset by increased expenses associated with the RECAP extension study, the Phase 2b study of RG7227 in patients chronically infected with HCV and the preparation of the NDA and MAA for pirfenidone.  

General and administrative (G&A) expenses were $10.6 million in the fourth quarter of 2009, compared with $7.9 million in the same period a year earlier, an increase of 34%.  G&A expenses were $37.5 million in the full year 2009, an increase of 23% from $30.6 million in 2008.  The additional G&A expenses are primarily attributed to costs related to preparation for the potential commercialization of pirfenidone, which is subject to regulatory approvals.

The net loss for the fourth quarter of 2009 was <
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Encision Inc. (OTCQB:ECIA), a medical device company owning ... in minimally invasive surgery, today announced financial results for ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $311 thousand, or $(0.04) per share, in the ...
(Date:7/29/2014)... , July 29, 2014   ... announced that it has taken an exclusive worldwide licence ... Ltd, a Durham University spin-out ... will pay an upfront fee, development and commercial milestone ... has also taken an option for additional exclusive licences ...
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
(Date:7/29/2014)... July 29, 2014 July 29, 2014 – ... care, is proud to announce that it is a Bronze ... online video segments; Silverado Through a Child's Eye ... , In Silverado Through a Child's Eye , seven-year-old ... mom at Silverado Beverly Place, a memory care community in ...
(Date:7/29/2014)... 29, 2014 Doug and Sandra Williams have ... and selling their grow-your-own log kits for almost that long. ... diet and a treat for their guests. A new ... to the Lost Creek Mushroom Farm online coverage. , They ... but soon turned to selling the logs instead of the ...
(Date:7/29/2014)... Palm City, Florida (PRWEB) July 29, 2014 ... premier providers of cold therapy products, announced today the ... newly designed hip wrap has been specifically created for ... comfort and enables the patient to enjoy the benefits ... , Hundreds of thousands of hip replacements are ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 This Latest ... Regulations to Practice (2014 Edition) not only provided a ... on clinical trials for imported drug registration but also ... Chinese GCP to guide you to use the Chinese ... in the “post-patent-cliff” world step by step. , The ...
(Date:7/29/2014)... procedure may enable more widespread use of preoperative testing ... with severe sleep apnea, suggests a study in ... and Dr. Jeff E. Mandel of the University of ... control" anesthetic technique for putting patients to sleep briefly-just ... apnea. The simplified technique requires no special expertise and ...
Breaking Medicine News(10 mins):Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 4Health News:New IsoComforter Cold Therapy Unit Plus Hip Wrap Gives Post Operative Hip Replacement Patients Faster Recovery Times 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 3
... may be an effective treatment for patients with a ... which was focused on the mechanism by which an ... important role because it suggests that changes in light ... inhibits mating of the C. neoformans -- a potentially ...
... risk of vertebral bone fractures in women with low bone ... 55 and 80 years with bone mineral density T scores ... women randomly received five milligrams of alendronate for two years ... placebo. ,The risk of vertebral fracture was significantly reduced ...
... and people without liver cancer found that diabetics are stand ... to the general population. ,After taking other factors into ... disease, researchers found diabetes nearly tripled the risk of liver ... factor for liver cancer, may be boosting the risk even ...
... be a treatment for life-threatening asthma (LTA) in children, according ... were treated with intravenous administration of sodium bicarbonate to reduce ... in LTA. , It was seen that in 17 ... was a decrease in blood carbon dioxide levels accompanied by ...
... the standard test to detect dementia so that it ... early. The test called National Institute //of Ageing's ... list (CWL) needs only ten minutes to administer. ... dementia as these stages often go undetected. They used ...
... as folate or a form of vitamin B. this vitamin if ... having a twin baby or to avoid //neural tube defect. A ... proof for this common belief. ,The study was conducted ... there are some countries were it is a common practice to ...
Cached Medicine News:
... for automated bioresearch . The ... offers flexibility, versatility, reliability and ... LS-50B, the LS 55 spectrometer ... accessories and software to address ...
Spectra 5000 is one of the most versatile analytical devices used in conventional laboratories which can work in the ultravoilet and visible range from 200 to 1000 nm for quantitative and qualitative...
... is a new generation Spectrophotometer for ... 320 nm to 1020 nm with ... computer and printer. It features four ... of transmittance, absorption and concentration with ...
... Spectrophotometer is truly a ... instrumentation. The latest electro-optical ... a radically new design, ... performance unprecedented in a ...
Medicine Products: